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INTRODUCTION
Schizophrenia is a disease that can devastate the
lives of people who suffer from it, and people with
it suffer distress, disability, reduced productivity,
and lowered quality of life (QOL). Over the past
two decades, the concept of QOL has become an
important attribute in patient care and research in
psychiatry area (1-3).
Although there seems to be no unanimous defi-
nition of QOL at the moment, there is general agree-
ment that QOL consists of access to resources and
opportunities, fulfillment of life’s roles, level of func-
tioning and a sense of well being or life satisfaction
(4, 5). As QOL is today regarded one of the most
important outcome measures, it is important to clar-
ify the clinical factors associated with lowered QOL.
Doing so can lead to more sophisticated treatment
strategies.
In this article, the author reviewed some existing
articles on measurement of QOL of schizophrenia
patients and clinical factors associated with QOL.
REVIEW
Quality of life and its predictors in people with schizo-
phrenia
Masahito Tomotake
Department of Mental Health, Institute of Health Biosciences, the University of Tokushima Graduate
School, Tokushima, Japan
Abstract : The author reviewed measurement of quality of life (QOL) of schizophrenia pa-
tients and the clinical factors related to their QOL. As schizophrenia patients were thought
to be unable to assess their own QOL because of their cognitive impairment, objective QOL
measures had been frequently used. However, nowadays, there is general agreement that
symptomatically stabilized patients could assess their QOL by themselves. Therefore, re-
searchers gradually have become interested in subjective QOL measure. Although most
researchers often evaluate schizophrenia patients’ QOL using only subjective or objective
QOL measure, considering the fact that there is a discrepancy between the two types of
measures, it is recommended to use both of them as complementary measures. As for clini-
cal factors related to lowered QOL, several studies reported that depressive symptom was
most associated with lowered subjective QOL, negative symptomwas strongly related to
lowered objective one and poor life skill was associated with both. Moreover, several
studies found that cognitive dysfunctions in some cognitive domains were related to low-
ered objective QOL but the effects of them were much smaller than those of negative
symptoms. It is suggested that improving depressive and negative symptoms and life
skills may contribute to enhancement of QOL of schizophrenia patients. J. Med. Invest.
58 : 167-174, August, 2011
Keywords : schizophrenia, quality of life, life skill, cognitive function
Received for publication April 21, 2011 ; accepted April 28, 2011.
Address correspondence and reprint requests to Masahito
Tomotake, M.D., Ph.D., Department of Mental Health, Institute
of Health Biosciences, the University of Tokushima Graduate
School, Kuramoto-cho, Tokushima 770-8503, Japan and Fax :
+81-88-633-9083.
The Journal of Medical Investigation Vol. 58 2011
167
MEASUREMENT OF QUALITY OF LIFE
Recently, there has been increasing interest in
QOL of people with schizophrenia, and now, QOL
measures are included routinely in most studies of
intervention or outcome (5, 6). However, not a few
problems have been identified with the implement
of the instruments. Such problems include the defi-
nition of the concept of QOL and the approach for
measurement of it. Although there is no unanimous
definition of QOL, the World Health Organization
defines QOL as individuals’ perception of their po-
sition in life in the context of culture and value sys-
tems in which they live and in relation to their goals,
expectations, standards, and concerns (7).
QOL of people with schizophrenia has been meas-
ured from two different viewpoints. One is a self-
rated measurement of QOL (subjective QOL) and
the other is an interviewer-rated measurement of
QOL (objective QOL). Although, according the defi-
nition by the World Health Organization, individu-
als’ perception of QOL seems to be vital, QOL of
schizophrenia patients had been frequently assessed
with objective QOL measures. Because of schizo-
phrenia patients’ cognitive impairment, they had
been thought to be unable to evaluate their own
QOL by themselves. However, nowadays, there is
general agreement that stabilized schizophrenia pa-
tients could assess their QOL by themselves (8).
Objective measures of QOL usually include indi-
cators of health and living conditions, sociodemog-
raphic items and role functioning in society, whereas
subjective measures of QOL do indicators of life
satisfaction in general and within different life do-
mains (5). For example, the Quality of Life Scale
(QLS) (9), one of the most frequently used objec-
tive QOL measures, was specifically constructed to
measure QOL of people with schizophrenia. The
QLS is a 21-item scale from a semistructured inter-
view providing information on symptoms and func-
tioning during the preceding 4 weeks. The QLS has
four subscales, Intrapsychic foundations, Interper-
sonal relations, Instrumental role, and Common ob-
jects and activities. Intrapsychic foundations subscale
items elicit judgments about intrapsychic elements
in the dimensions of cognition, conation, and affec-
tivity seen as near the core deficit of schizophrenia.
Interpersonal relations subscale relates to various as-
pects of interpersonal and social experience. Instru-
mental role subscale focuses on the role of worker,
student, or housekeeper/parent. Common objects
and activities subscale is based on the assumption
that a robust participation in the community is re-
flected in the possession of common objects and
the engagement in regular activities (9).
As for subjective QOL instruments, although not
a few subjective QOL instruments exist to assess
health-related QOL, it is said that they can some-
times overlook the QOL concerns of specific patients
groups. Recently, Wilkioson et al. (10) constructed
schizophrenia disease specific subjective QOL in-
strument that is called the Schizophrenia Quality
of Life Scale (SQLS). The SQLS consists of three
scales that are Psychosocial, Motivation and energy,
and Symptoms and side-effect. Lower scores indi-
cate higher QOL. The Japanese version of it is often
used in studies in Japan (11).
RELATION BEWEEN SUBJECTIVE AND
OBJECTIVE QUALITY OF LIFE MEASURES
Researchers have been paying attention to the re-
lation between subjective and objective QOL meas-
ures. Although many studies used only one of them,
if they reflect different aspects of QOL and have
different predictors, doing so is likely to introduce
bias in the results. However, there are only a few
studies investigating the relation between them.
Using the Quality of Life Interview which contains
subjective and objective measures, Dickerson et al.
(12) studied 72 outpatients with schizophrenia and
demonstrated that there were few significant cor-
relations between subjective and objective QOL in-
dicators of specific life areas. Fitzgerald et al. (5)
found that life satisfaction and objectively rated QOL
are not closely related, and concluded that subjec-
tive and objective QOL had different determinants
in patients with schizophrenia.
To explore the relationship between subjective
and objective QOL measures, we conducted a strict
research using schizophrenia disease specific sub-
jective and objective QOL measures (13). In the
cross-sectional study, 99 symptomatically stabilized
outpatients with a DSM-IV diagnosis of schizophre-
nia were assessed with the SQLS (10, 11) and the
QLS (9). The correlations between the scores on
scales of the SQLS and the QLS total and subscales
in the study are shown in Table 1. The score of the
Motivation and energy scale correlated significantly
with the QLS total score, Interpersonal relations,
Instrumental role, Intrapsychic foundations, and
Common Objects and activities subscales. More-
over, the score of the Psychosocial scale showed a
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significant but weak correlation with the QLS total
score. The score of the Symptoms and side-effects
scale did not correlate significantly with the QLS
scores.
Considering these results indicating that there
were only a few significant correlations between
the SQLS and the QLS scores, researchers should
use both of subjective and objective QOL measures
as complementary outcome measures in order to
avoid introducing bias.
RELATION BETWEEN CLINICAL SYMP-
TOMS AND QUALITY OF LIFE
As for the clinical symptoms associated with sub-
jective QOL, Dickerson et al. (1998) found that
schizophrenia patients’ subjective QOL measured
by the Quality of Life Interview was significantly
related to the depression factor in the Positive and
Negative Syndrome Scale (PANSS). Huppert et al.
(14) also found that more severe depression as
rated on the Brief Psychiatric Rating Scale (BPRS)
was associated with lower subjective QOL measured
by the Quality of Life Interview. Other similar stud-
ies support the significant association of depres-
sive symptom with subjective QOL (5, 15). As for
subjective well-being which is the main component
of subjective QOL, Norman et al. (16) reported that
the General Well-Being Scale score was significantly
related to positive symptom, particularly reality dis-
tortion. These results suggest that depressive and
positive symptoms may be important factors in-
fluencing schizophrenia patients’ subjective QOL.
Moreover, other clinical factors such as anxiety, ex-
trapyramidal adverse effects, and patients’ subjec-
tive responses and attitudes towards antipsychotic
treatment have been found to be significantly asso-
ciated with subjective QOL (1, 14, 15).
Clinical factors related to objective QOL also
have been investigated, and several research groups
reported that negative symptom was much more
closely related to objective QOL than was positive
symptom (5, 16). As the studies used the QLS
which was originally designed to assess deficit
symptoms of schizophrenia, it may stand to reason
that fewer negative symptoms were associated with
better QOL assessed by the QLS. However, some
studies showed the significant associations of posi-
tive symptom and other clinical factors with the QLS
(17-20).
We investigated the relationship between several
clinical factors (duration of illness, number of hos-
pitalization, dose of neuroleptics, positive symptom,
negative symptom, extrapyramidal symptom, and
depressive symptom) and QOL in outpatients with
schizophrenia (13). The results of stepwise regres-
sion analyses on the SQLS and the QLS in the study
are shown in Table 2. Psychosocial scale score was
predicted independently by the Calgary Depression
Scale for Schizophrenia (CDSS) score, the BPRS
positive symptoms score, dose of neuroleptics, and
the BPRS negative symptoms score. The CDSS
score contributed significantly to the prediction of
the Motivation and energy scale score. Symptoms
and side-effects scale score was predicted independ-
ently by the BPRS positive symptoms score, the
CDSS score, and dose of neuroleptics. The QLS to-
tal score was predicted independently by the BPRS
negative symptoms score and the BPRS positive
symptoms score. The BPRS negative symptoms
score and duration of illness contributed independ-
ently to the prediction of the Interpersonal relations
subscale. Instrumental role subscale was predicted
independently by the BPRS negative symptoms
score and the BPRS positive symptoms score. The
Intrapsychic foundations subscale was also predicted
by the BPRS negative symptoms score and the
Table 1 Correlation between Schizophrenia Quality of Life Scale and Quality of Life Scale (N=99) (from Ref.13 Tomotake M, et al.
Psychol Rep 99, 477-487, 2006)
SQLS
Psychosocial Motivation and energy Symptoms and side- effects
QLS Total -.20 * -.40 *** -.16
Interpersonal relations -.19 -.42 *** -.16
Instrumental role -.19 -.28 ** -.14
Intrapsychic foundations -.19 -.39 *** -.14
Common objects and activities -.10 -.25 * -.14
* p0.05, ** p0 .01, *** p0.001.
SQLS=Schizophrenia Quality of Life Scale, QLS=Quality of Life Scale.
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BPRS positive symptoms score. The BPRS negative
symptoms score and duration of illness contributed
independently to the prediction of the Common
objects and activities subscale.
In general, these findings seem to indicate that
depressive symptom is the most important predic-
tor of subjective QOL and negative symptom is the
most important one of objective QOL.
RELATION BETWEEN LIFE SKILLS AND
QUALITY OF LIFE
There are a few studies that investigated the re-
lationship between life skill and QOL in people with
schizophrenia. Norman et al. (16) reported the sig-
nificant relationships among life skill, subjective
QOL and objective QOL in subjects with schizophre-
nia or schizoaffective disorder. On the other hand,
Parker et al. (21) reported no significant correlation
between life skill and subjective QOL.
Recently, Aki et al. (22) investigated the relation
between life skills and QOL in schizophrenia pa-
tients. In the study, they used the Life Skills Profile
(LSP) to evaluate life skills of patients with schizo-
phrenia, and subjective QOL and objective QOL
were assessed the SQLS and the QLS, respectively.
The LSP was designed by Rosen et al. (23) to as-
sess survival and adaptation in the community by
individuals with severe mental illness. The LSP is
a thirty nine-item questionnaire. Each item is rated
from 1 to 4 and a higher score indicates a greater
level of life skills. The LSP has five subscales that
are Self-care, Non-turbulance, Socialization, Com-
munication, and Responsibility. Table 3 shows the
results of correlation analyses between the SQLS,
the QLS and the LSP in the study. The LSP total
score correlated with scores of the SQLS and the
Table 2 Summary of stepwise regression analyses on Schizophrenia Quality of Life Scale and Quality of Life Scale (N=99) (from
Ref.13 Tomotake M, et al. Psychol Rep 99, 477-487, 2006)
Dependent variables Independent variables Adjusted R2 β
SQLS Psychosocial CDSS .48*** .58***
BPRS positive symptoms .42***
Dose of neuroleptics -.22**
BPRS negative Symptoms -.18*
Motivation and energy CDSS .23*** .48***
Symptoms and side-effects BPRS positive symptoms .21*** .37**
CDSS .27**
Dose of neuroleptics -.20*
QLS Total BPRS negative symptoms .46*** -.53***
BPRS positive symptoms -.24**
Interpersonal relations BPRS negative symptoms .36*** -.60***
Duration of illness -.21*
Instrumental role BPRS negative symptoms .28*** -.33**
BPRS positive symptoms -.31**
Intrapsychic foundations BPRS negative symptoms .53*** -.59***
BPRS positive symptoms -.24**
Common objects and activities BPRS negative symptoms .33*** -.58***
Duration of illness -.19*
* p0.05, ** p0.01, *** p0.001.
SQLS=Schizophrenia Quality of Life Scale, QLS=Quality of Life Scale, CDSS=Calgary Depression Scale for Schizophrenia, BPRS=
Brief Psychiatric Rating Scale.
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QLS, which seems to indicate that basic life skills
have some effects on schizophrenia patients’ QOL.
Especially, life skills about self-care and socializa-
tion are important factors.
From the findings, it is suggested that improving
life skills may lead to enhancement of schizophre-
nia patients’ QOL. However, a prospective research
will be needed to clarify this.
RELATION BETWEEN COGNITIVE FUNC-
TION AND QUALITY OF LIFE
Cognitive problems have been considered a core
component of schizophrenia. However, they have
only recently been considered as potential treatment
targets (24). Recently, it has become apparent that
there are several aspects of impaired neurocogni-
tion that are consistently found in schizophrenia.
Such cognitive dysfunctions are paid much more
attention because they are thought to lead to poor
social functioning.
Some research groups reported that functional
magnetic resonance imaging (fMRI), positron emis-
sion tomography (PET), and electroencephalogram
(EEG) show relations between neuroanatomical
measures and cognitive deficits in schizophrenia
patients, and these relations are particularly found
in frontal regions, temporal cortex, and hippocam-
pus (24). And it has been reported that cognitive
functions of schizophrenia patients were of the or-
der of one to two standard deviations below the
mean of healthy controls in several cognitive dimen-
sions, particularly memory, attention, verbal fluency,
and executive function (25-28).
These cognitive dysfunctions are thought to be
associated with lowered social activity, poor ac-
quisition of social skills during the rehabilitation
programme, and lowered QOL. Some previous re-
search groups have investigated the relation be-
tween QOL and cognitive function in people with
schizophrenia, and reported the significant correla-
tions between QOL and some domains of cognitive
function such as verbal memory, vocabulary, fluency
performance, attention, social knowledge, and ex-
ecutive function (12, 28, 29-32).
From the results of previous studies, it seems to
be clear that cognitive dysfunctions and some clini-
cal symptoms are significantly correlated with low-
ered QOL in schizophrenia patients. However, it re-
mains unclear how much impact these factors have
on their QOL. Some studies demonstrated that cog-
nitive dysfunction had a greater influence on schizo-
phrenia patients’ QOL than positive symptoms (33-
35). On the other hand, some reported that neu-
ropsychological function had a little impact on their
QOL in the presence of some clinical symptoms (32,
36). The discrepancy among these studies might
have been caused by differences of sample popula-
tion, cognitive tests, and QOL scales (32-34, 36).
To elucidate the relation between cognitive func-
tion and QOL in schizophrenia patients, Yamauchi
et al. (37) investigated the relations between the
SQLS, the QLS, and the PANSS cognitive factor
in 84 outpatients with schizophrenia. The results
showed that although the PANSS cognitive factor
was significantly correlated with both of the SQLS
and the QLS, it seemed to have a greater influence
on the QLS score than the SQLS score.
Recently, our research group (38) conducted a
Table 3 Correlation among Schizophrenia Quality of Life Scale, Quality of Life Scale and Life Skills Profile (N=64) (from Ref.22
Aki H, et al. Psychiatry Res 158, 19-25, 2008)
SQLS QLS
Psychosocial Motivationand energy
Symptoms
and
side-effects
Total Interpersonalrelations
Instrumental
role
Intrapsychic
foundation
Common
objects and
activities
LSP
Total -0.47** -0.41* -0.46** 0.55** 0.48** 0.56** 0.49** 0.47**
Self -care -0.40* -0.32 -0.43** 0.52** 0.46** 0.54** 0.45** 0.49**
Non-turbulence -0.44** -0.25 -0.43** 0.16 0.08 0.24 0.17 0.13
Socialization -0.36 -0.44** -0.28 0.63** 0.57** 0.57** 0.57** 0.50**
Communication -0.33 -0.31 -0.37* 0.37 0.32 0.39* 0.33 0.27
Responsibility -0.24 -0.17 -0.25 0.26 0.22 0.29 0.23 0.26
*p0.05, **p0.01 (Bonferroni correction).
SQLS=Schizophrenia Quality of Life Scale, QLS=Quality of Life Scale, LSP=Life Skills Profile.
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strict study to elucidate the relation between cog-
nitive function and QOL by using the Brief Assess-
ment of Cognition in Schizophrenia (BACS) (39, 40)
that is a newly developed neuropsychological bat-
tery for assessing cognitive function of schizophre-
nia patient. The BACS has been developed for clini-
cal trials with a brief battery of tests for measuring
cognition. It assesses the aspects of cognition that
were found to be most impaired and most strongly
correlated with outcome in patients with schizophre-
nia. The domains of cognitive function evaluated by
the BACS are Verbal memory (List learning), Work-
ing memory (Digit sequencing task), Motor speed
(Token motor task), Verbal fluency (Category in-
stances and Controlled oral word association test),
Attention and speed of information processing (Sym-
bol coding), and Executive function (Tower of
London) (39).
In our study (40), Z-score for Verbal memory was
-1.68 (SD=1.28), that for Working memory -1.23
(SD=1.78), that for Motor speed -1.81 (SD=1.64),
that for Attention and speed of information proc-
essing -1.66 (SD=1.19), that for Verbal fluency -0.82
(SD=1.11), and that for Executive function -1.20
(SD=1.95), showing that cognitive performance of
schizophrenia patients were much disturbed than
healthy controls. The correlations between the QLS
scores and the BACS scores are shown in Table 4.
The BACS Composite score, Attention and speed
of information processing score, and Verbal mem-
ory score showed significant and positive correla-
tions with the QLS total and all or some subscale
scores. In the study, stepwise regression analyses
when using several clinical variables including the
BACS scores as independent variables showed that
the QLS total score was significantly predicted by
the PANSS negative syndrome scale score, the
CDSS score, and the BACS Attention and speed of
information processing score. The results were
rather consistent with those of previous researches
in terms of that cognitive dysfunction was on the
whole related to lowered objective QOL (28, 30, 37).
In addition, we also investigated the relation be-
tween subjective QOL and cognitive function and
reported that there was no significant correlation
between them (41).
CONCLUSIONS
Subjective and objective QOL measures have dif-
ferent predictors in people with schizophrenia. De-
pressive symptom is most related to subjective QOL,
negative symptom is most associated with objective
one, and basic life skills are related to both. Cogni-
tive dysfunctions in some neurocognitive domains
are associated with lowered objective QOL, but the
effects of them are much smaller than negative and
depressive symptoms. It is suggested that improv-
ing depressive and negative symptoms and basic
life skills may contribute to enhancement of QOL
of schizophrenia patients.
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